Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reliability of Indocyanine Green in Sentinel Lymph Node Identification
NCT02997553Phase 3Completed
- Sponsor
- Institut de Cancérologie de Lorraine
- Start
- Nov 2017
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indocyanine green in breast cancer, head and neck cancer (HNC), melanoma, squamous cell carcinoma (SCC), Cervical Cancer (CC), sponsored by Institut de Cancérologie de Lorraine. Started Nov 2017; status: completed.
02
Drugs
indocyanine green
03
Conditions
breast cancerhead and neck cancer (HNC)melanomasquamous cell carcinoma (SCC)Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02997553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02997553.